Deciphering the Enigma: A Comprehensive Approach to Evaluating Unexplained Weight Loss in Clinical Practice
OthersPage Navigation
Introduction
Unexplained weight loss (UWL), defined as a loss of 5% or more of body weight within a six to twelve month period, often poses a diagnostic challenge to clinicians due to its multifactorial etiology.
Evaluation Strategy
An effective approach begins with a thorough history and physical exam, focusing on symptoms that might suggest an underlying systemic disease. Investigations should be guided by clinical suspicion, rather than a shotgun approach.
Common Causes
Common causes include malignancy, gastrointestinal disorders, endocrine abnormalities, and psychiatric conditions. Rarely, infectious diseases or autoimmune disorders may be implicated.
Role of Imaging
Imaging studies, such as CT scans or endoscopies, can be useful in certain cases. However, their routine use in the absence of specific indications may not be cost-effective.
Conclusion
Decoding the mystery of UWL requires a systematic approach, balancing the need for a comprehensive evaluation with judicious use of resources. Early recognition and appropriate management of the underlying cause can significantly improve patient outcomes.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.
2.
FDA Investigating Blood Cancer Risk With Gene Therapy Skysona
3.
Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer
4.
In early dementia, SSRIs enhance cognition and major depression.
5.
TCL1A Protein Identified as Predictor of Blinatumomab Response in Relapsed B-ALL
1.
Oncologic Emergencies: Diagnosis and Treatment
2.
Strategic Standards in Hematology for Specialists
3.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
4.
Advanced Breakthroughs in Hematology and Patient Outcomes
5.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part IX
2.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
3.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge